189 related articles for article (PubMed ID: 35964686)
21. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
[TBL] [Abstract][Full Text] [Related]
22. Rab7 reduces α-synuclein toxicity in rats and primary neurons.
Szegö EM; Van den Haute C; Höfs L; Baekelandt V; Van der Perren A; Falkenburger BH
Exp Neurol; 2022 Jan; 347():113900. PubMed ID: 34695425
[TBL] [Abstract][Full Text] [Related]
23. Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.
Cui H; Kilpeläinen T; Zouzoula L; Auno S; Trontti K; Kurvonen S; Norrbacka S; Hovatta I; Jensen PH; Myöhänen TT
J Cell Mol Med; 2021 Oct; 25(20):9634-9646. PubMed ID: 34486218
[TBL] [Abstract][Full Text] [Related]
24. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
25. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
[TBL] [Abstract][Full Text] [Related]
26. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.
Sekiya H; Tsuji A; Hashimoto Y; Takata M; Koga S; Nishida K; Futamura N; Kawamoto M; Kohara N; Dickson DW; Kowa H; Toda T
Acta Neuropathol Commun; 2022 Sep; 10(1):133. PubMed ID: 36068646
[TBL] [Abstract][Full Text] [Related]
27. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.
Saramowicz K; Siwecka N; Galita G; Kucharska-Lusina A; Rozpędek-Kamińska W; Majsterek I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203531
[TBL] [Abstract][Full Text] [Related]
28. Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in
Arsac JN; Sedru M; Dartiguelongue M; Vulin J; Davoust N; Baron T; Mollereau B
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769043
[TBL] [Abstract][Full Text] [Related]
29. Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.
Savolainen MH; Yan X; Myöhänen TT; Huttunen HJ
J Biol Chem; 2015 Feb; 290(8):5117-5126. PubMed ID: 25555914
[TBL] [Abstract][Full Text] [Related]
30. Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease.
Arawaka S; Fukushima S; Sato H; Sasaki A; Koga K; Koyama S; Kato T
PLoS One; 2014; 9(2):e89076. PubMed ID: 24586512
[TBL] [Abstract][Full Text] [Related]
31. Dopamine-Induced Oligomers of α-Synuclein Inhibit Amyloid Fibril Growth and Show No Toxicity.
Galkin M; Topcheva O; Priss A; Borisova T; Shvadchak VV
ACS Chem Neurosci; 2023 Jun; 14(11):2027-2034. PubMed ID: 37162160
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
[TBL] [Abstract][Full Text] [Related]
34. Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro.
Cucinotta L; Mannino D; Casili G; Repici A; Crupi L; Paterniti I; Esposito E; Campolo M
Respir Res; 2023 Aug; 24(1):211. PubMed ID: 37626373
[TBL] [Abstract][Full Text] [Related]
35. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
36. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
[TBL] [Abstract][Full Text] [Related]
37. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
[TBL] [Abstract][Full Text] [Related]
38. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
[TBL] [Abstract][Full Text] [Related]
39. Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.
Drobny A; Boros FA; Balta D; Prieto Huarcaya S; Caylioglu D; Qazi N; Vandrey J; Schneider Y; Dobert JP; Pitcairn C; Mazzulli JR; Zunke F
Transl Neurodegener; 2023 Jun; 12(1):31. PubMed ID: 37312133
[TBL] [Abstract][Full Text] [Related]
40. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
Liu CW; Giasson BI; Lewis KA; Lee VM; Demartino GN; Thomas PJ
J Biol Chem; 2005 Jun; 280(24):22670-8. PubMed ID: 15840579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
